Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer | MicrobiomeTrials← Back to trialsNCT05830838
Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2023-07-28Est. Completion: 2029-05-30
Enrollment target: 50 participants Locations- Mayo Clinic in Rochester, Rochester, Minnesota, United States
Other microbiome trials you might be interested in
Renal Tumor HistologyCutaneous LeiomyomaKidney Cancer
This study will investigate what causes hereditary leiomyomatosis renal (kidney) cell cancer, or HLRCC, and how the dise…
Bethesda, United States
Breast NeoplasmsColorectal NeoplasmsProstate NeoplasmEndometrial NeoplasmsNeoplasm MetastasisStomach NeoplasmsEsophageal Neoplasms
The main purpose of this study is to evaluate safety, tolerability, and efficacy of LY4257496 alone and as part of relev…
Duarte, United StatesEst. completion Apr 2030